The EASL Liver Cancer Summit 2026 is a multidisciplinary scientific meeting dedicated to the study and management of primary liver cancers, specifically hepatocellular carcinoma (HCC) and cholangiocarcinoma.

Scheduled for January 22–24, 2026, in Edinburgh, the summit provides a technical forum for hepatologists, oncologists, surgeons, and interventional radiologists to discuss advancements in molecular pathogenesis, genomic profiling, and emerging systemic therapies. Organized by the European Association for the Study of the Liver (EASL), the event includes peer-reviewed abstract presentations and sessions on healthcare resource optimization and patient advocacy.

Register.